Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Jan. 29, 2016	Jan. 30, 2015
Operating Activities:
Net (loss) income	$ (40,221)	$ 30,525
Adjustments to continuing operations:
Depreciation and amortization	40,087	33,679
Changes in deferred income taxes	(849)	14,479
Contributions to defined benefit employee pension plans	(1,418)	(10,846)
Defined benefit employee pension and postretirement plan expense (income)	6,217	(6,186)
Share-based compensation expense	4,367	7,554
Changes in long-term receivables	6,740	2,350
Other adjustments to continuing operations, net	3,589	833
Changes in working capital items attributed to continuing operations:
Accounts receivable, net	146,678	138,034
Inventories	26,917	(113,544)
Other current assets	(2,658)	(16,370)
Trade accounts payable	(54,900)	(65,315)
Employee compensation and benefits	(8,883)	(48,076)
Advance payments and progress billings	8,957	42,497
Accrued warranties	(85)	(6,593)
Other accrued liabilities	(25,949)	(21,376)
Net cash provided (used) by operating activities	108,589	(18,355)
Investing Activities:
Property, plant and equipment acquired	(8,103)	(22,258)
Proceeds from sale of property, plant and equipment	9,167	756
Other investing activities, net	122	141
Net cash provided (used) by investing activities	1,186	(21,361)
Financing Activities:
Common stock issued	0	273
Dividends paid	(997)	(19,489)
Repayments of term loan	(4,687)	0
Payments on credit agreement	(58,600)	0
Repayments of short term debt	(1,507)	0
Financing fees	(1,011)	0
Treasury stock purchased	0	(50,000)
Other financing activities, net	0	440
Net cash used by financing activities	(66,802)	(68,776)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	5,925	9,373
Increase (Decrease) in Cash and Cash Equivalents	37,048	(117,865)
Cash and Cash Equivalents at Beginning of Period	102,885	270,191
Cash and Cash Equivalents at End of Period	$ 139,933	$ 152,326